Cite
APA Citation
Banerjee, S., Ledermann, J., Matulonis, U., Molife, L., Friedlander, M., Fielding, A., Robertson, J., Spencer, S., McMurtry, E., & Kaye, S. (n.d.). 2759 Management of nausea and vomiting during treatment with the capsule (CAP) and tablet (TAB) formulations of the PARP inhibitor olaparib. European journal of cancer, 51, S550–. http://access.bl.uk/ark:/81055/vdc_100030628283.0x000060